HU219482B - (+)Doxazoszin alkalmazása vizeletfolyást fokozó gyógyászati készítmények előállítására - Google Patents

(+)Doxazoszin alkalmazása vizeletfolyást fokozó gyógyászati készítmények előállítására Download PDF

Info

Publication number
HU219482B
HU219482B HU9501286A HU9501286A HU219482B HU 219482 B HU219482 B HU 219482B HU 9501286 A HU9501286 A HU 9501286A HU 9501286 A HU9501286 A HU 9501286A HU 219482 B HU219482 B HU 219482B
Authority
HU
Hungary
Prior art keywords
doxazosin
pharmaceutical compositions
use according
acid
blood pressure
Prior art date
Application number
HU9501286A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9501286D0 (en
HUT73678A (en
Inventor
Nancy M. Gray
Original Assignee
Sepracor Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc. filed Critical Sepracor Inc.
Publication of HU9501286D0 publication Critical patent/HU9501286D0/hu
Publication of HUT73678A publication Critical patent/HUT73678A/hu
Publication of HU219482B publication Critical patent/HU219482B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
HU9501286A 1992-11-04 1993-11-02 (+)Doxazoszin alkalmazása vizeletfolyást fokozó gyógyászati készítmények előállítására HU219482B (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97068592A 1992-11-04 1992-11-04
PCT/US1993/010503 WO1994009785A2 (en) 1992-11-04 1993-11-02 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis

Publications (3)

Publication Number Publication Date
HU9501286D0 HU9501286D0 (en) 1995-06-28
HUT73678A HUT73678A (en) 1996-09-30
HU219482B true HU219482B (hu) 2001-04-28

Family

ID=25517324

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9501286A HU219482B (hu) 1992-11-04 1993-11-02 (+)Doxazoszin alkalmazása vizeletfolyást fokozó gyógyászati készítmények előállítására

Country Status (11)

Country Link
US (1) US5508279A (ko)
EP (1) EP0667775A1 (ko)
JP (1) JPH08502977A (ko)
KR (1) KR950703961A (ko)
AU (1) AU5546194A (ko)
CA (1) CA2147866A1 (ko)
HU (1) HU219482B (ko)
NO (1) NO308196B1 (ko)
NZ (1) NZ257993A (ko)
RU (1) RU2139053C1 (ko)
WO (1) WO1994009785A2 (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120302A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
US6177430B1 (en) 1997-03-27 2001-01-23 Pfizer Inc Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
US6200573B1 (en) 1999-12-03 2001-03-13 Starcor Pharmaceuticals, Inc. Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia
IL141235A (en) * 2000-02-09 2012-04-30 Novartis Int Pharm Ltd Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
US6596686B2 (en) 2001-03-12 2003-07-22 International Flavors & Fragrances Inc. Use of dihydropyrans as fragrance Material
PT1443917E (pt) * 2001-11-07 2006-06-30 Synthon Bv Comprimidos de tamsulosina
US7175127B2 (en) * 2002-09-27 2007-02-13 C.G. Bretting Manufacturing Company, Inc. Rewinder apparatus and method
KR20050092519A (ko) * 2004-03-16 2005-09-22 화이자 인코포레이티드 아토르바스타틴 및 α1-아드레날린성 수용체 길항제의 조합
WO2006031024A1 (en) * 2004-09-15 2006-03-23 Gl Pharmtech Corp. A sustained-release tablet containing doxazosin mesylate
CN1769285B (zh) * 2004-11-05 2010-05-05 华北制药集团新药研究开发有限责任公司 光学活性的多沙唑嗪盐
CN102321079B (zh) * 2005-11-11 2013-08-28 华北制药集团新药研究开发有限责任公司 (-)多沙唑嗪甲磺酸盐vi型结晶、其制备方法及用途
CN107951852A (zh) * 2017-12-31 2018-04-24 威海贯标信息科技有限公司 一种多沙唑嗪片组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188390A (en) * 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
US5212176A (en) * 1990-06-29 1993-05-18 Abbott Laboratories R(+)-terazosin
IL101243A (en) * 1991-03-20 1999-12-22 Merck & Co Inc Pharmaceutical preparations for the treatment of benign prostatic hyperplasia containing steroid history

Also Published As

Publication number Publication date
EP0667775A1 (en) 1995-08-23
NO951718L (no) 1995-05-03
WO1994009785A2 (en) 1994-05-11
HU9501286D0 (en) 1995-06-28
WO1994009785A3 (en) 1994-08-04
NZ257993A (en) 1997-05-26
JPH08502977A (ja) 1996-04-02
RU2139053C1 (ru) 1999-10-10
KR950703961A (ko) 1995-11-17
HUT73678A (en) 1996-09-30
NO308196B1 (no) 2000-08-14
NO951718D0 (no) 1995-05-03
US5508279A (en) 1996-04-16
AU5546194A (en) 1994-05-24
CA2147866A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
DE602004007225T2 (de) Methode zur behandlung von erkrankungen der unteren harnwege
US6281207B1 (en) Treatment of movement disorders by administration of mirtazapine
US5547993A (en) Therapeutic agent for glaucoma
US20070270459A1 (en) Overactive bladder treating drug
IE57793B1 (en) Orally administerable antidiabetic compositions
HU219482B (hu) (+)Doxazoszin alkalmazása vizeletfolyást fokozó gyógyászati készítmények előállítására
JPH04264030A (ja) 抗喘息剤
EP0345304B1 (en) Pharmaceutical compositions
KR100443891B1 (ko) 당뇨병성합병증의예방·치료제
JP2015512919A (ja) 塩酸レルカニジピンおよびロサルタンカリウム配合剤およびその調製法
WO2020072774A1 (en) Combination therapy for the treatment of uveal melanoma
CN108774220B (zh) 用于治疗心肌缺血的化合物及其应用
US5510352A (en) Methods of using (+) doxazosin for the treatment of hypertension
JP2011246478A (ja) テルカゲパントカリウムの固形投与製剤
WO1994009783A1 (en) Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
CN1137686C (zh) 椎管狭窄的治疗药
JPH0741424A (ja) 抗炎症剤
US8470862B2 (en) Treatment or prevention of hypotension and shock
CN1149086C (zh) 改善视神经乳头循环的药物
CN1501802A (zh) 芳基乙烯磺酰胺衍生物的新用途
JPH09227381A (ja) 脳血栓における運動麻痺の改善剤
JPH0827029A (ja) ５ｈｔ１ 作動薬の新規医薬用途
WO1994009782A1 (en) Methods and compositions of (-) doxazosin for the treatment of hypertension
HU206612B (en) Process for producing antihypertenzive combinative composition
US20040048776A1 (en) Medicament for preventive and therapeutic treatment of fibrosis

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee